Characteristics of patients with hypertension included in the EIGHT study, according to their use of traditional medicine
| Use of traditional medicine | P value* | Missing N | ||
| No | Yes | |||
| N | 1616 | 512 | ||
| Age (mean (SD)) | 57.99 (11.97) | 59.18 (11.19) | 0.05 | 0 |
| Male sex (n (%)) | 598 (37.0) | 244 (47.7) | <0.001 | 0 |
| Hypertension (n (%)) | 0.05 | 12 | ||
| Controlled | 382 (23.8) | 101 (19.8) | ||
| Mild | 474 (29.5) | 154 (30.3) | ||
| Moderate | 416 (25.9) | 122 (24.0) | ||
| Severe | 335 (20.8) | 132 (25.9) | ||
| Systolic blood pressure (mean (SD)) | 148.07 (23.29) | 152.03 (24.48) | 0.001 | 12 |
| Diastolic blood pressure (mean (SD)) | 87.99 (14.05) | 89.32 (14.96) | 0.07 | 15 |
| Time since hypertension diagnostic (n (%)) | 0.41 | 44 | ||
| <1 year | 240 (15.2) | 77 (15.3) | ||
| 1–5 years | 820 (51.9) | 280 (55.7) | ||
| 6–9 years | 231 (14.6) | 65 (12.9) | ||
| >10 years | 290 (18.3) | 81 (16.1) | ||
| Low-income country (n (%)) | 748 (46.3) | 232 (45.3) | 0.74 | 0 |
| Individual wealth index (n (%)) | 0.22 | 52 | ||
| High | 536 (33.8) | 152 (30.9) | ||
| Middle | 769 (48.5) | 261 (53.0) | ||
| Low | 279 (17.6) | 79 (16.1) | ||
| Place of residence (n (%)) | 0.001 | 40 | ||
| Rural | 88 (5.6) | 52 (10.3) | ||
| Semirural | 226 (14.3) | 68 (13.5) | ||
| Urban | 1271 (80.2) | 383 (76.1) | ||
| No of treatments for hypertension (mean (SD)) | 1.95 (0.92) | 1.86 (0.90) | 0.05 | 0 |
| Type of treatment | 0 | |||
| Calcium inhibitor (n (%)) | 910 (58.0) | 261 (53.5) | 0.09 | |
| Diuretic (n (%)) | 878 (56.0) | 253 (51.8) | 0.12 | |
| Converting enzyme inhibitor (n (%)) | 710 (45.3) | 241 (49.4) | 0.12 | |
| Betablocker (n (%)) | 351 (22.4) | 100 (20.5) | 0.42 | |
| Angiotensin II antagonist (n (%)) | 240 (15.3) | 75 (15.4) | 1.00 | |
| Central antihypertensive (n (%)) | 57 (3.6) | 21 (4.3) | 0.59 | |
| Vasodilator (n (%)) | 23 (1.5) | 8 (1.6) | 0.95 | |
| Poor treatment adherence (n (%)) | 1007 (62.3) | 379 (74.0) | <0.001 | 0 |
| Reported missing treatment because of its cost (n (%)) | 381 (24.1) | 168 (33.3) | <0.001 | 40 |
| Number of complications of hypertension (n (%)) | 0.001 | 93 | ||
| 0 | 894 (57.9) | 245 (49.9) | ||
| 1 | 511 (33.1) | 191 (38.9) | ||
| 2 | 119 (7.7) | 39 (7.9) | ||
| 3 or more | 20 (1.3) | 16 (3.3) | ||
| Type of complications (n (%)) | 93 | |||
| Renal | 104 (6.7) | 50 (10.2) | 0.02 | |
| Cardiac | 407 (26.4) | 152 (31.0) | 0.05 | |
| Cerebral | 133 (8.6) | 62 (12.6) | 0.01 | |
| Ocular | 162 (10.5) | 48 (9.8) | 0.71 | |
| Cardiovascular disease risk factors (n (%)) | 545 | |||
| Current tobacco smoking | 56 (4.5) | 21 (6.2) | 0.24 | |
| Diabetes | 208 (16.7) | 69 (20.5) | 0.12 | |
| Hypercholesterolaemia | 255 (20.4) | 55 (16.4) | 0.11 | |
| Hypertriglyceridaemia | 60 (4.8) | 23 (6.8) | 0.18 | |
| Obesity | 251 (20.1) | 75 (22.3) | 0.42 | |
| Sedentary lifestyle | 494 (39.6) | 129 (38.4) | 0.73 | |
*P alue is for t-test (continuous) of χ2 (categorical variables).